These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7267676)
21. [Alpha blocking properties of dihydro ergot derivatives. Findings on skin and muscle temperature]. D'Ayala Valva G; Dabizzi RP; Banchelli A Riv Crit Clin Med; 1967 Aug; 67(3):191-9. PubMed ID: 4395433 [No Abstract] [Full Text] [Related]
22. [Measurements of skin temperature for the testing of a blood flow promoting ointment]. Sommer R; Watschinger B Hippokrates; 1969 Jun; 40(12):479-84. PubMed ID: 5824508 [No Abstract] [Full Text] [Related]
23. [Effects of xanthinol nicotinate on the irrigation of the musculature of the limbs and of the skin]. Klüken N; Schmidt H Angiologia; 1972; 24(6):271-80. PubMed ID: 4641643 [No Abstract] [Full Text] [Related]
24. [Therapeutic physical exercise in the preoperative preparation of patients with obliterative vascular diseases of the legs]. Kulikov IuA; Dzhuraeva LA; Avazmatova KhR; Ismailova DA Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):53-5. PubMed ID: 2711639 [No Abstract] [Full Text] [Related]
25. Relationship of lower extremity skin blood flow to the ankle brachial index in patients with peripheral arterial disease and normal volunteers. Otah KE; Otah E; Clark LT; Salifu MO Int J Cardiol; 2005 Aug; 103(1):41-6. PubMed ID: 16061122 [TBL] [Abstract][Full Text] [Related]
26. No recovery of cold complex regional pain syndrome after transdermal isosorbide dinitrate: a small controlled trial. Groeneweg JG; Huygen FJ; Niehof SP; Wesseldijk F; Bussmann JB; Schasfoort FC; Stronks DL; Zijlstra FJ J Pain Symptom Manage; 2009 Sep; 38(3):401-8. PubMed ID: 19515530 [TBL] [Abstract][Full Text] [Related]
27. Differences in vasodilatory response to dipyridamole between patients with angina and normal coronary arteries and patients with successful coronary angioplasty. Finocchiaro ML; Buffon A; Beltrame JF; Lupi A; Conti E; Lanza GA; Cianflone D; Crea F; Maseri A Coron Artery Dis; 1995 Jun; 6(6):479-87. PubMed ID: 7551269 [TBL] [Abstract][Full Text] [Related]
28. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial. Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502 [TBL] [Abstract][Full Text] [Related]
29. Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users. Sullivan JT; Becker PM; Preston KL; Wise RA; Wigely FM; Testa MP; Jasinski DR Am J Med; 1997 Mar; 102(3):232-8. PubMed ID: 9217590 [TBL] [Abstract][Full Text] [Related]
30. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance]. Nedjabat T; Ebinger H; Birtel FJ Med Welt; 1976 Aug; 27(34):1585-7. PubMed ID: 948260 [No Abstract] [Full Text] [Related]
31. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407 [TBL] [Abstract][Full Text] [Related]
32. [Study on normal subjects on the hemodynamic effect of nicotinic acid and of its higher homologue 3-pyridil-acetic acid. IV. Behavior of the rheogram]. Cosentino F; Saponaro A; Giordano G; Verde AM; Crispo M; Dagianti A Boll Soc Ital Cardiol; 1966; 11(2):232-40. PubMed ID: 5334141 [No Abstract] [Full Text] [Related]
34. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. van Royen N; Schirmer SH; Atasever B; Behrens CY; Ubbink D; Buschmann EE; Voskuil M; Bot P; Hoefer I; Schlingemann RO; Biemond BJ; Tijssen JG; Bode C; Schaper W; Oskam J; Legemate DA; Piek JJ; Buschmann I Circulation; 2005 Aug; 112(7):1040-6. PubMed ID: 16087795 [TBL] [Abstract][Full Text] [Related]
35. Conditions for dipyridamole potentiation of skeletal muscle active hyperemia. Klabunde RE Am J Physiol; 1986 Jan; 250(1 Pt 2):H62-7. PubMed ID: 3942237 [TBL] [Abstract][Full Text] [Related]
36. [Effect of bencyclane in obliterative arterial diseases]. Kusztos D Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658 [No Abstract] [Full Text] [Related]
37. The significance of vasodilator therapy in obliterative arterial disease. Thulesius O Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925 [No Abstract] [Full Text] [Related]
38. [Intraoperative measurement of peripheral resistance in arterial circulatory disturbances and the effect of acetylcholine and nicotinic acid]. Heinrich P; Förster HJ Z Exp Chir; 1971; 4(3):148-51. PubMed ID: 5162948 [No Abstract] [Full Text] [Related]
39. [Effects of the nicotinic ester of 7(2-hydroxyethyl)-theophylline on peripheral arteriopathies in the aged]. Bandinelli G; De Mauro G; Provvedi D; Bellini PG; Rubegni M Cardiol Prat; 1973; 24(3):275-80. PubMed ID: 4779825 [No Abstract] [Full Text] [Related]
40. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease. Bielawiec M; Kiersnowska-Rogowska B; Dabrowski S; Lukjan H Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]